Citation Tools
Poster Presentation
Rheumatoid arthritis - anti-TNF therapy
FRI0186 Long-term safety and efficacy of 4-weekly certolizumab pegol monotherapy and combination therapy in rheumatoid arthritis: 5-year results from an open-label extension study
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- FRI0186 Long-term safety and efficacy of 4-weekly certolizumab pegol monotherapy and combination therapy in rheumatoid arthritis: 5-year results from an open-label extension study